Blujepa (gepotidacin) Approved by US FDA as Oral Option for Treatment of Uncomplicated Urogenital Gonorrhea (uGC)

Dec 12, 2025 - 03:00
 0  1
London, UK December 11, 2025 -- GSK plc (LSE/NYSE: GSK) today announced that the US Food and Drug Administration (FDA) has approved a supplemental New Drug Application for Blujepa (gepotidacin) as an oral option for adult and paediatric patients...

What's Your Reaction?

Like Like 0
Dislike Dislike 0
Love Love 0
Funny Funny 0
Angry Angry 0
Sad Sad 0
Wow Wow 0